A six-month crossover chemoprevention clinical trial of tea in smokers and non-smokers: methodological issues in a feasibility study

Table 3 **Participant characteristics by treatment compliance* among participants who completed the crossover tea study**

Characteristic	Compliant (N = 23)	Non-compliant (N = 9)
	(%)	(%)
Age, mean (SD)	35 (11)	28 (10)
Male	48	33
Race/Ethnicity
White	44	44
African-American	13	-
Hispanic	4	11
Asian	35	44
Other	4	-
Smoking status
Current	39	22
Former	4	11
Never	57	67
Regular alcohol intake	22	33
Regular tea intake	44	33
Regular coffee intake	59	33
Regular carbonated beverages intake	36	22
Fruit/vegetable servings/day, mean (SD)	2.4 (1.4)	2.4 (1.0)
BMI, mean (SD)	24.9 (3.6)	22.1 (2.8)

^a P value <0.05 for comparison between “compliant” and “non-compliant”.
^b 0.05 ≤ P value < 0.10 for comparison between “compliant” and “non-compliant”.
^c 0.10 ≤ P value < 0.15 for comparison between “compliant” and “non-compliant”.
* Treatment non-compliance defined as consumption of <85% of the packets provided for at least one of the four treatments.
Regular intake <2 servings per day. Participants reporting ≥2 servings per day consumption of tea, coffee, carbonated beverages, or alcohol were excluded from the trial.

ISSN: 2662-7671